abstract |
(57) [Problem] To provide a vaccine against feline immunodeficiency virus comprising a polynucleotide as an active ingredient. The present invention relates to a vaccine composition that can be used to protect cats against feline immunodeficiency virus. More particularly, the present invention relates to polynucleotide molecules that can be used as vaccine compositions against feline immunodeficiency virus. |